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IMPORTANCE Differentiating recurrent nevi from recurrent melanoma is challenging.
OBJECTIVE To determine dermoscopic features to differentiate recurrent nevi from
melanomas.
DESIGN, SETTING, AND PARTICIPANTS Retrospective observational study of 15 pigmented
lesion clinics from 12 countries; 98 recurrent nevi (61.3%) and 62 recurrent melanomas
(38.8%) were collected from January to December 2011.
MAIN OUTCOMES ANDMEASURES Scoring the dermoscopic features, patterns, and colors in
correlation with the histopathologic findings.
RESULTS In univariate analysis, radial lines, symmetry, and centrifugal growth pattern were
significantly more common dermoscopically in recurrent nevi; in contrast, circles, especially if
on the head and neck area, eccentric hyperpigmentation at the periphery, a chaotic and
noncontinuous growth pattern, and pigmentation beyond the scar's edge were significantly
more common in recurrent melanomas. Patients with recurrent melanomas were significantly
older than patients with recurrent nevi (mean [SD] age, 63.1 [17.5] years vs 30.2 [12.4] years)
(P< .001), and there was a significantly longer time interval between the first procedure and
the second treatment (median time interval, 25 vs 8months) (P< .001). In a multivariate
analysis, pigmentation beyond the scar’s edge (P= .002), age (P< .001), and anatomic site
(P= .002) were significantly and independently associated with the diagnosis of recurrent
melanoma in dermoscopy.
CONCLUSIONS AND RELEVANCE Dermoscopically, pigmentation beyond the scar’s edge is the
strongest clue for melanoma. Dermoscopy is helpful in evaluating recurrent lesions, but final
interpretation requires taking into account the patient age, anatomic site, time to recurrence,
growth pattern, and, if available, the histopathologic findings of the first excision.
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D ermoscopy is used in pigmented and nonpigmentedlesions of the skin, nail apparatus, hair, and volar andmucosal areas.1-7 Scars revealing recurrence of pig-
ment followingabiopsyorotherproceduresperformedonme-
lanocytic neoplasms can be difficult to interpret both clini-
cally and dermoscopically. Numerous case reports have been
published.8-13 Botella-Estrada et al14 performed the largest
studyandanalyzed the clinical, dermoscopic, andhistopatho-
logic characteristicsof 57 recurrentmelanocytic lesions.Toob-
tain a larger number of cases, the International Dermoscopy
Society (IDS) launched a multicenter retrospective, observa-
tional study to determine dermoscopic characteristics to dif-
ferentiate recurrent nevi from recurrent melanomas.15
Methods
Patient Selection and Design
In this retrospectiveobservational study,patients’dataandder-
moscopic images of histopathologically diagnosed recurrent
nevi and recurrent melanomas were included from 15 pig-
mented lesion clinics in 12 countries (Argentina, Austria, Bel-
gium, Brazil, France, Germany, Italy, Japan, Mexico, Roma-
nia, Spain, and the United States).
Lesions were collected from January through December
2011 via an e-mail request sent to all IDSmembers.15 For each
lesion, a patient data intake form and clinical and digital der-
moscopicpolarizedand/ornonpolarized,high-resolution, and
in-focus images in JPEG format were required. It was also re-
quired thatdermoscopic imagesof all lesionsvisualize the scar
from the first procedure. The following patient datawere col-
lected for each lesion: sex; age; skin type; anatomic site; type
ofprocedureperformedat timeof first intervention; initial his-
topathologic report and diagnosis at first procedure, if avail-
able, including tumor thickness for melanomas; time be-
tween the first and second procedures; and histopathologic
diagnosis of the second procedure, including tumor thick-
ness for recurrentmelanoma. The anatomic sites were classi-
fied as head and neck, upper extremities, trunk, lower ex-
tremities, and nails. Mucosal lesions were excluded.
All data and digital images were assigned a unique iden-
tifier, anonymized, and sent via e-mail to the study coordina-
tor (A.B.).The institutional reviewboardapproval for this study
waswaived by the ethics committee (Medical Council Baden-
Wuerttemberg, Stuttgart, Germany). Written informed con-
sent was not necessary and was not requested.
The histopathologic diagnoses rendered by each partici-
pating institution’s dermatopathologist were accepted as the
final diagnoses.
Analysis of Dermoscopic Images
All digital imageswere reviewed in consensus by 2 of us (A.B.
andR.H.-W.),whowere blinded to bothhistopathologic diag-
noses. Each lesion was scored according to the principles of
pattern analysis for the presence of the following basic
elements16,17: lines (classified as reticular, branched, parallel,
radial, and/or curved), pseudopods, circles, globules or clods,
and dots. Each element could form its own pattern; for ex-
ample, a nevus consisting of reticular lines would result in a
reticular pattern. If none of the basic elements was present,
thepatternwas termedstructureless. Lesions revealinga com-
bination of patterns were classified according to the number
of presented patterns. The presence of a single dot or a single
line does not constitute a pattern. In this study, the term pat-
ternwas defined as a collection of multiple basic elements of
the same type, for example, multiple dots that cover a con-
siderable part (≥20%) of the lesion. Colors were classified as
black, brown, blue, gray, red, purple, andwhite, and thenum-
ber of colors was counted. Each lesion was evaluated for de-
gree of symmetry in 1 or 2 axes, the presence of eccentric hy-
perpigmentation at theperiphery, growthpattern (centrifugal
[like an outward force that draws a rotating body away from
the center of rotation], chaotic, or neither), noncontinuous
growth pattern, vessels within the scar and outside the scar,
and presence of pigmentation beyond the scar’s edge (pig-
ment traversing the scar edge, extending from the scar onto
normal skin).10
Statistical Analysis
Continuousdata are givenasmeans (SDs) or as themedian (in-
terquartile range). χ2 Tests or Fisher exact tests were used for
the comparison of proportions. Continuous data were com-
paredwith unpaired t tests orMann-Whitney U test as appro-
priate. Logistic regression analysiswas used for themultivar-
iate model. We constructed 2 models for the diagnosis of
recurrent melanocytic lesions. In the first model, we in-
cluded those variables thatwere significantly associatedwith
melanoma in the multivariate analysis (ie, age > 30 years, lo-
cation on the head and neck area, and pigmentation travers-
ing the scar’s edge). Positive criteriawereadded toa final score
ranging from0to3, and theareaunder thecurve for thismodel
was calculated. To calculate sensitivity, specificity, andnega-
tive and positive predictive values, we chose a cutoff of 2 (ie,
if ≥2 criteriawerepresent, the lesionwas considered tobema-
lignant). For this model, we disregarded the histopathologic
diagnosis report associatedwith the firstprocedure. In the sec-
ondmodel,we took thehistopathologic report of the first pro-
cedure into account. For those lesions that were initially di-
agnosedasmelanoma,weadded2points, and for those lesions
diagnosed as nevi, we subtracted 1 point. If no histopatho-
logic report was available, then no value was added or sub-
tractedfromthefinal score.This resulted inscores rangingfrom
−1 to 4.We chose the same cutoff as for the first model to cal-
culate sensitivity, specificity, and negative and positive pre-
dictive values. All given P values are 2-tailed, and P < .05 in-
dicates statistical significance.
Results
General Data
The study consistedof 160 recurrentmelanocytic nevi and re-
current melanomas from 98 females (61.3%) and 51 males
(31.9%); for 11 cases (6.9%) thesexdataweremissing.Themean
(SD) age of the patients was 43.1 (21.7) years. The final histo-
pathologic diagnosis was recurrent nevus in 98 cases (61.3%)
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and recurrentmelanoma in62 cases (38.8%). Patientswith re-
currentmelanomaswere significantlyolder thanpatientswith
recurrent nevi (mean [SD] age, 63.1 [17.5] years vs 30.2 [12.4]
years;P < .001).Nodifferencewas foundwith regard to the sex
distribution of patients with recurrent nevi (58.2% were fe-
males) and recurrentmelanoma (66.1%were females).Regard-
inganatomic site, 32 recurrent lesionswere locatedonthehead
andneck (20.0%), 11 on theupper extremities (6.9%), 72 at the
trunk (45.0%), 41on the lowerextremities (25.6%), and2 in the
nail unit (1.3%); for 2 lesions, this data variable was not avail-
able (1.3%) (Table 1). Recurrent melanomas were more fre-
quently locatedon theheadandneck area than recurrentnevi
(46.8% vs 3.1%; P < .001).
For most lesions (131 [81.9%]), the first treatment per-
formed was a surgical procedure), such as shave, sauceriza-
tion, punch, or excisional biopsy. One lesionwas treatedwith
surgery followed by imiquimod application (0.6%). In addi-
tion, 8 lesions were initially treated by laser (5.0%) and 4 by
cryotherapy (2.5%), 4 lesions recurred after trauma (2.5%), 3
were treated with cauterization (1.9%), and for 9 lesions the
procedure of the first encounter was not reported (5.7%). For
110 cases, the histopathologic diagnosis of the first procedure
was available and included 66 nevi (41.3%) and 44 melano-
mas (27.5%); in 50 lesions (32 nevi and 18melanomas) thehis-
topathologic diagnosis of the first treatment was unavailable
(31.1%). In all 160 recurrent lesions, the histopathologic diag-
nosis was available.
The median time interval between the first and second
treatmentwas 18months (25th-75thpercentile, 6-41months).
Patients with recurrent melanomas had a longer time inter-
val between the 2 treatment thanpatientswith recurrent nevi
(median, 25 months [25th-75th percentile, 12-48 months] vs
8 months [25th-75th percentile: 5-24 months]; P < .001).
Dermoscopic Patterns and Colors
Frequencies of dermoscopic features and colors according to
the final diagnosis are given inTable 2. Radial linesweremore
common in recurrentnevi than in recurrentmelanoma (29.6%
vs 8.1%; P < .001). Because recurrent melanoma was found
more frequently on the face, circlesweremore commonly ob-
served in recurrentmelanomas than in recurrent nevi (33.9%
vs 7.1%; P < .001). Dermoscopic pattern of recurrent nevi was
more often symmetric and that of recurrent melanomas was
asymmetric (18.4%vs6.5%;P = .04). Eccentric hyperpigmen-
tationat theperipherywasmoreoftenvisible inrecurrentmela-
noma than in recurrent nevi (37.1%vs 21.4%;P = .045). A cen-
trifugal pattern was more common in recurrent nevi than in
recurrent melanomas (46.9% vs 12.9%), whereas a chaotic
growth pattern wasmore often in recurrent melanomas than
in recurrent nevi (59.7% vs 22.4%). A noncontinuous growth
patternwas less oftenvisible in recurrent nevi comparedwith
recurrent melanomas (29.6% vs 53.2%; P = .004).
Pigmentation traversing the scar’s edge was less often
found in recurrent nevi than in melanomas (42.9% vs 87.1%;
P < .001).Nosignificantdifferencecouldbedemonstratedwith
regard to the pseudopods, globules or clods, dots, structure-
less areas, colors, number of features or colors, and vessels
within or outside the lesion or scar (Table 2).
Multivariate Analysis and Diagnostic Model
Amultivariatemodel, including all significant variables of the
univariateanalysis (age,anatomicsite, timetorecurrence, sym-
metry, presence of radial lines or circles, presence of eccen-
tric hyperpigmentation, growth pattern, and presence of pig-
mentation beyond the scar’s edge), showed that location on
the head and neck area (odds ratio [OR], 20.2 [95% CI, 3.0-
137.2];P = .002), ageolder than30years (OR,48.5 [95%CI, 5.5-
426.1];P < .001), andpigmentationbeyondthescar’s edge (OR,
4.0 [95% CI, 1.2-12.9]; P = .002) were independently associ-
ated with recurrent melanoma. Based on the multivariate
analysis, we constructed 2 diagnostic models to aid the clini-
cian with the decision regarding whether a recurrent lesion
should be biopsied or not. The first model disregards the ini-
tial histopathologic report of the first procedure; the second
model takes this report into account. In the first model, the
number of recurrent melanoma–associated criteria (location
on the head and neck area, age > 30 years, and pigmentation
beyond the scar’s edge) were added to a score ranging from 0
to3. If at least 2 of the criteriawerepresent, themodel reached
a sensitivity of 88.7%, a specificity of 74.0%, a negative pre-
dictivevalueof91.0%,andapositivepredictivevalueof68.8%
formelanoma. This first model reached an area under the re-
ceiver operating characteristic (ROC) curve of 0.88 (95% CI,
0.83-0.94). In the secondmodel, we added 2 points for those
lesions that were diagnosed initially as melanoma and sub-
tracted 1 point for those thatwerediagnosed asnevi. If nohis-
topathologic report was available then nothing was added or
subtracted from the total score. Thus, the scores for the sec-
ondmodel ranged from−1 to 4.We chose the same cutoff of 2
points as was done in the first model to calculate sensitivity,
specificity, and negative and positive predictive values. At a
cutoff of at least 2 points the model reached a sensitivity of
Table 1. Data of the Anatomic Sites of All Recurrent Lesions, Recurrent Nevi, and RecurrentMelanomas
Site
Recurrent Lesions, No. (%)a
All Nevi Melanomas
Head and neck 32 (20.0) 3 (3.1) 29 (46.8)
Upper extremities 11 (6.9) 5 (5.1) 6 (9.7)
Trunk 72 (45.0) 65 (66.3) 7 (11.3)
Lower extremities 41 (25.6) 22 (22.4) 19 (30.6)
Nails 2 (1.3) 1 (1.0) 1 (1.6)
Missing 2 (1.3) 2 (2.0) 0
Total 160 (100) 98 (100) 62 (100)
a Percentages may not total 100%
owing to rounding.
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88.7%, a specificity of 85.7%, a negative predictive value of
92.3%, and a positive predictive value of 79.7% for mela-
noma.This secondmodel reachedanareaunder theROCcurve
of 0.94 (95% CI, 0.90-0.98).
Discussion
Thismulticenter, retrospective, observational study of 98 re-
current nevi (Figure 1) and62 recurrentmelanomas (Figure 2)
bythe IDSdemonstratedthatpigmentationtraversingthescar’s
edge is the strongest clue for recurrentmelanoma in dermos-
copy.Other significant factors associatedwith recurrentmela-
noma were circles, chaotic growth pattern, and noncontinu-
ous growth in dermoscopy and the location on the head and
neck area, age older than 30 years, and longer time to recur-
rence.
In daily clinical practice it is difficult to differentiate re-
current nevi from recurrentmelanoma. Incomplete removals
of melanocytic neoplasms by shave or punch biopsy, exci-
sion, laser treatment, or after trauma often present with re-
currence of pigment. Formany recurrent lesions it is difficult
or impossible to obtain theoriginal pathology report or slides.
Furthermore, thepresenceofmelanocytichyperplasiaorpseu-
domelanoma-like features can make it difficult for the pa-
thologist to rule out amelanoma.Botella-Estradaet al14 stated
that 28%of the lesions in their study recurredaftervarious sur-
gical procedures and revealed pseudomelanoma-like fea-
turesonpathologicexamination.Also, inflammationcancause
pigment or melanocytic hyperplasia in scars, which leads to
confusion.14 A histological review of 722 reexcised scars after
initial removal of nonmelanocytic tumors revealed that in 8%
therewasmelanocytic hyperplasia, and in somecases amela-
noma in situ was difficult to exclude.18 In 30% of melanoma
scars and in 25% of nonmelanoma scars there was evidence
of variable degrees ofmelanocytic hyperplasia.19 Thus, to en-
sure themostaccuratediagnosis, it is recommendedthatwhen-
ever possible, the original pathology slides be reviewed, and,
if the lesion is reexcised, that the pathologic findings be re-
viewed by a dermatopathologist. But should all recurrent le-
sionsbe reexcised?Naturally, any recurrent lesion that proved
to be amelanomaon the original biopsy needs to be retreated
appropriately. What about recurrent lesions that were origi-
nallydiagnosedasnevi,or recurrent lesions forwhich theorigi-
Table 2. Features and Colors Correlating to Recurrent Nevi and RecurrentMelanomas
Pattern or Color
Recurrent, No. (%)
P ValueNevi Melanomas
Lines 77 (78.6) 36 (58.1) .007
Reticular 22 (22.4) 15 (24.2) .85
Branched 8 (8.2) 3 (4.8) .53
Parallel 27 (27.6) 20 (32.3) .60
Radial 29 (29.6) 5 (8.1) <.001
Curved 8 (8.2) 7 (11.3) .58
Pseudopods 7 (7.1) 1 (1.6) .15
Circles 7 (7.1) 21 (33.9) <.001
Globules or clods 27 (27.6) 18 (29.0) .86
Dots 56 (57.1) 26 (42.6) .10
Structureless 48 (49.0) 33(53.2) .63
Color
Black 35 (35.7) 19 (30.6) .61
Brown 98 (100.0) 59 (95.2) .06
Blue 4 (4.1) 6 (9.7) .19
Gray 23 (23.5) 20 (32.3) .27
Red 6 (6.1) 4 (6.5) >.99
Purple 1 (1.0) 2 (3.2) .56
White 0 (0.0) 3 (4.8) .06
Symmetry 18 (18.4) 4 (6.5) .04
Eccentric hyperpigmentation
at the periphery
21 (21.4) 23 (37.1) .045
Growth pattern
Centrifugal 46 (46.9) 8 (12.9)
<.001Chaotic 22 (22.4) 37 (59.7)
None 30 (30.6) 17 (27.4)
Noncontinuous growth pattern 29 (29.6) 33 (53.2) .004
Vessels inside 4 (4.1) 5 (8.1) .31
Vessels outside 25 (25.5) 14 (22.6) .71
Pigmentation beyond the
scar’s edge
42 (42.9) 54 (87.1) <.001
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nal pathology slides are unavailable? It is precisely this ques-
tion that the present IDS study was designed to answer.15
Besidescasereports8-13 the largest studyonthis subjectwas
performedbyBotella-Estradaetal.14Theyanalyzedclinicaland
dermoscopic featuresof 57 recurrentmelanocytic tumorswith
a classification into4 categories: reactivepigmented scarwith
macular,banded,ordiffusepigmentation(72.6%); recurrentne-
vus (24.2%); recurrentmelanoma (1.1%); andmetastaticmela-
nomas (2.1%). In thehistopathologic examination, 56.1%were
classified as reactive hyperpigmentation; 38.6% were recur-
rentnevi; 1.8%, recurrent; and3.5%,metastaticmelanoma.Ac-
cordingtodermoscopic featurestheycomprised2groups, 1with
reactive pigmentation and 1 with recurrent nevi andmelano-
mas. Comparing the anatomic site, Botella-Estrada et al14 in-
cluded5.3%fromtheheadandneckarea (vs 20%inour study),
6.3%fromtheupperextremities (vs6.9%),75.8%fromthetrunk
(vs45%), 6.3%fromthe lower extremities (vs 25.6%), and6.3%
fromthehandsandfeet (vs1.3%fromthenailarea inourstudy).
Based on differing methods of classification and numbers of
melanomas, direct comparison of the study by Botella-
Estrada et al with ours is difficult.
Our study revealed that patients with recurrent melano-
maswere significantly older thanpatientswith recurrent nevi
(63.1 vs 30.2 years). This age difference between the 2 groups
couldbe a reflectionof thehigher pretest probability that a bi-
opsiedmelanocytic lesion in anolder individualwill bemela-
noma, and, in contrast, that younger patients more often de-
mand a treatment for cosmetic reasons.
Themediantimeintervalbetweenthefirstandsecondtreat-
mentwas 18months (25months for recurrentmelanomas vs 8
months for recurrent nevi), but the interval lost its signifi-
cance in multivariate analysis. A significant proportion of the
recurrent melanomas may preferentially be of the slow-
growing type.20,21 It is possible that lesions simply recur faster
in youth and take longer to recur in older individuals. Unfortu-
nately, thenumberof cases inour studywas toosmall toevalu-
ate “time to recurrence” as a function of (stratified by) age.
Botella-Estrada et al14 reported a mean time of 4 months
(range, 1-14months) to recurrentpigmentation in43 scars, but
no difference in time to recurrence between nevi and mela-
noma was specified. They14 named dermoscopic features as
streaks, pigmented network, dots and globules, background
homogeneous pigmentation, bluish white veil, heteroge-
neouspigmentation, andvascular structures. Thepresenceof
globules and heterogeneous pigmentation was the strongest
dermoscopic finding (P < .001) for recurrent nevi, followedby
prominent irregular network (P = .045) andabsenceof streaks
(P = .047), and these features were helpful in differentiating
Figure 1. Dermoscopic Images of Recurrent Nevi
A B
C D
A, Lesion found on aman in his 30s with a recurrent nevi after a
histopathologically diagnosed nevus on the trunk. The time between first and
second treatments was not available. In the dermoscopic examination, radial
lines, black and brown colors, and distinct symmetry were visible. B, Lesion
found on a woman in her 20s with a recurrent nevus on the lower extremities.
No histopathologic results were available 6months after the first treatment. In
the dermoscopic examination radial lines, pseudopods, dots, black and brown
colors, and a nearly centrifugal and continuous growth pattern were seen. C,
Lesion found on aman in his 40s with a recurrent nevus on the trunk. Twelve
months earlier, surgery had been performed; however, no histopathologic
results were available. In the dermoscopic examination, reticular and distinct
radial lines, brown colors, and eccentric hyperpigmentation at the periphery
were visible. D, Lesion found on aman in his 30s with a recurrent nevus on the
leg. Six months earlier, a nevus had been histopathologically diagnosed. In the
dermoscopic examination, radial lines, circles, dots, brown and gray colors, and
a centrifugal and continuous growth pattern around a hair follicle were
detectable. The scale is in millimeters. Reproduced with permission of Memorial
Sloan Kettering Cancer Center.
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between reactive hyperpigmentation and recurrent melano-
cytic neoplasms.14 In contrast, our study was specifically de-
signed to look for features to help differentiate recurrent nevi
frommelanoma. Radial lines, aswell as a symmetric and cen-
trifugal growthpattern,weremoreoftenseen in recurrentnevi
(Box).
Circles, eccentrichyperpigmentationat theperiphery, cha-
otic and noncontinuous growth pattern, as well as pigmenta-
tion traversing the scar’s edge were more often found in re-
current melanomas. Some of these observations have been
describedpreviously in a fewcase reports.8-13 Thepresenceof
circles is closely linked to the anatomic location of the lesion;
they aremore commonly found in recurrentmelanomaof the
face (65.5%) than in recurrentmelanoma on other body areas
(6.1%). Unfortunately, the number of cases in this study pre-
cluded us from stratifying the data based on location.
Helpful dermoscopic elements andpatterns to differenti-
ate recurrent nevi from recurrent melanoma are listed in the
Box.Hocker et al22 showed thatnomelanomasdevelopeddur-
ing long-term follow-up after incompletely or narrowly re-
moveddysplasticnevi.TallonandSnow23 reported that in 1035
nevi and 196 dysplastic nevi the rate of recurrence requiring
reexcisionwas only 0.3%. Goodson et al24 arrived at the same
conclusion in their studywith over 2 years of follow-up of in-
complete removalof271neviand195dysplasticnevi.Allgroups
concluded that reexcision of incompletely removed nevi, in-
cluding mildly to moderately dysplastic, may not be
necessary.22-24 However, in cases of repigmentation in which
the original diagnosis was melanoma, it remains imperative
Box. Characteristic Dermoscopic Pattern of Recurrent Nevi and
RecurrentMelanomas
Recurrent Nevus
Radial lines
Symmetry
Centrifugal growth pattern
RecurrentMelanoma
Circles (face especially)
Eccentric hyperpigmentation at the periphery
Chaotic growth pattern
Noncontinuous growth pattern
Pigmentation beyond the scar’s edge
Figure 2. Dermoscopic Images of RecurrentMelanoma
A B
C D
A, Lesion found on a woman in her 60s with a 0.4-mm–thick tumor on the
trunk. Ten years earlier, a nevus had been histopathologically diagnosed. In the
dermoscopic examination, parallel lines; clods; dots; black, brown, and red
colors; an eccentric hyperpigmentation at the periphery; and a chaotic and
noncontinuous growth pattern with pigmentation beyond the scar’s edge were
detectable. B, Lesion found on aman in his 30s with a 0.9-mm–thick tumor on
the lower extremities. Twomonths earlier, an invasive 1.25-mm–thick melanoma
had been diagnosed. In the dermoscopic examination, structureless areas;
clods; brown, gray, and red colors; eccentric hyperpigmentation at the
periphery; polymorphia of vessels; and pigmentation beyond the scar’s edge
were detectable. C, Lesion found on aman in his 70s with a 0.27-mm–thick
tumor in the head and neck area. Nineteenmonths earlier, an invasive
1.28-mm–thick melanoma had been treated with surgery and imiquimod. In the
dermoscopic examination, circles, dots, brown and gray colors, eccentric
hyperpigmentation at the periphery, a chaotic and noncontinuous growth
pattern, and pigmentation beyond the scar’s edge were detectable. D, Lesion
found on a woman in her 30s with a 0.50-mm–thick tumor on her trunk.
Forty-twomonths earlier, an invasive 0.45-mm–thick melanoma had been
diagnosed. In the dermoscopic examination, parallel and radial lines, brown and
gray colors, and a very distinct asymmetric growth pattern were visible.
Reproduced with permission of Memorial Sloan Kettering Cancer Center.
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to rule out recurrentmelanoma. Perhapsnewnoninvasive di-
agnostic tools, such as confocalmicroscopy,mayalsobehelp-
ful in the future.12
Our study has several limitations: the design was retro-
spective, and there was no assurance that all consecutive re-
current lesions seen in each participant’s clinic were entered
into the study. This may have inadvertently led to the inclu-
sion of only the atypical cases because they weremore likely
tobephotographicallydocumentedthanrecurrent lesionswith
minimal pigment or lesions with uninteresting dermoscopic
morphologic characteristics. Thehistopathology slides of the
first and second procedures were not reviewed by a central
study pathologist with an acknowledgement and acceptance
of interobserver agreement among pathologists. In addition,
the lesions’ elements and colors were classified by consen-
sus, and thus no interobserver concordancewas reported. Fi-
nally, there were numerous significant discriminating fea-
tures found on univariate analysis (Table 2 and the Box);
however, onmultivariate analysis, only older age, locationon
theheadandneckarea, andpresenceofpigmentation travers-
ing the scar’s edge retained significance. Thenumber of cases
included in this study precluded us from evaluating the sig-
nificance of features (Table 2) stratified by age and location.
In summary, recurrent melanomas were strongly associ-
ated with age older than 30 years, longer time of recurrence,
circles on the head and neck area, eccentric hyperpigmenta-
tion at the periphery, chaotic andnoncontinuous growth pat-
tern, and pigment traversing the scar’s edge (Box). Recurrent
nevi were associated with age younger than 30 years, shorter
time to recurrence, radial lines, symmetry, and a centrifugal
growth pattern; in these lesions dermoscopicmonitoring in 2
to 3months is a reasonable option.25 However, an excision bi-
opsyofanydoubtful recurrent lesion indermoscopy is thegold
standard treatment at present.
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NOTABLENOTES
AShort History of Tattoo
Filippo Pesapane, MD; Gianluca Nazzaro, MD; Raffaele Gianotti, MD; Antonella Coggi, MD
Tattoo is apermanentpigmentationof the skin resulting fromthe intro-
duction of exogenous substances. If this happens unintentionally—for
example, after road injuries—it is called traumatic tattoo. However, the
most common tattoos are decorative, related to current fashion or to a
symbolic meaning.
The etymological origin of theword tattoo is believed to have 2ma-
jor derivations: the first is from the Polynesian word “ta” which means
“striking something,” and the second is the Tahitianword “tatau”which
means “tomark something.” Thiswordwas introduced inEuropeby the
English explorer James Cook, who described the Polynesian technique
of “tattaw” in his narrative of the voyage.
The oldest example of tattoo dates back to 3000 BC and is repre-
sented by amummy called “Ötzi the Iceman” discovered from the area
of the Italian-Austrian border in 1991.1 Radiological examination of his
bones showed osteochondrosis in areas where tattoos had been pres-
ent. It has been speculated that these tattoosmayhavebeen related to
pain relief treatmentssimilar toacupuncture. If so, thispracticemayhave
existed at least 2000 years before its previously known earliest use in
China.2
In ancient times the tattoo spread throughout Egypt and Rome un-
til itwasbannedbytheEmperorConstantineafterhisconversiontoChris-
tianity. Constantine believed that the human image was a representa-
tion of God and should not be disfigured or defiled. The practice of
tattooing thebodywasnever fully acceptedbyanyof the3greatmono-
theistic religions (Christianity, Judaism,and Islam).Althoughtattooswere
forbidden among Christians by Pope Hadrian I in 787, the habit of tat-
tooing the body survived secretly, especially in some places of Chris-
tian worship, like the Sanctuary of Loreto, where the “Friars-Tattooist”
(“Frati-marcatori”) tattoo, a small devotional sign to the pilgrims, was
used.
The reintroduction of the tattoo in the Western world occurred af-
ter theoceanexpeditionsof the 18thcentury.At theendof the 19thcen-
tury theuseof tattooing spreadamonghighestEuropean social classes:
famous “celebrity” tattoos included thoseofTsarNicholas II andSirWin-
stonChurchill. In recentdecades thepracticeof tattoohaswidely spread
in theWestern world to all social classes, with an increase of complica-
tions related to it, such as allergic, lichenoid, granulomatous, and pseu-
dolymphomatous reactions or induction of skin diseases.3
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